BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou C, Fan N, Liu F, Fang N, Plum PS, Thieme R, Gockel I, Gromnitza S, Hillmer AM, Chon SH, Schlösser HA, Bruns CJ, Zhao Y. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells 2020;9:E1481. [PMID: 32560537 DOI: 10.3390/cells9061481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wen S, Qin Y, Wang R, Yang L, Zeng H, Zhu P, Li Q, Qiu Y, Chen S, Liu Y, Hou Y, Tang X, Liu M, Tu G. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels. Cell Death Dis 2021;12:437. [PMID: 33934099 DOI: 10.1038/s41419-021-03708-6] [Reference Citation Analysis]
2 Zhou C, Wang Z, Li J, Wu X, Fan N, Li D, Liu F, Plum PS, Hoppe S, Hillmer AM, Quaas A, Gebauer F, Chon SH, Bruns CJ, Zhao Y. Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification. Cancers (Basel) 2021;13:2403. [PMID: 34065695 DOI: 10.3390/cancers13102403] [Reference Citation Analysis]
3 Narusaka T, Ohara T, Noma K, Nishiwaki N, Katsura Y, Kato T, Sato H, Tomono Y, Kikuchi S, Tazawa H, Shirakawa Y, Matsukawa A, Fujiwara T. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer. Int J Cancer 2021;149:347-57. [PMID: 33662150 DOI: 10.1002/ijc.33544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Das PK, Islam F, Smith RA, Lam AK. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas. Front Oncol 2020;10:598957. [PMID: 33665161 DOI: 10.3389/fonc.2020.598957] [Reference Citation Analysis]
5 Gronnier C, Collet D. New Trends in Esophageal Cancer Management. Cancers (Basel) 2021;13:3030. [PMID: 34204314 DOI: 10.3390/cancers13123030] [Reference Citation Analysis]